Futura Medical plc (AIM:FUM)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 2.37M -91.5% |
| Revenue (ttm) | 1.70M -87.8% |
| Net Income | -9.07M |
| EPS | -0.03 |
| Shares Out | 581.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.4990 |
| Previous Close | 0.4500 |
| Day's Range | 0.3700 - 0.4990 |
| 52-Week Range | 0.2440 - 10.5000 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2026 |
About Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom. [Read more]
Financial Performance
Financial StatementsNews
AIM Market Roundup: Focus Xplore, Futura Medical, Bravura Solutions
Focus Xplore, Futura Medical, Bravura Solutions, 80 Mile and Celsius Resources are today's biggest movers on London's AIM market
AIM Market Roundup: The Mission Group, Shaires Holdings, Eleco Public
The Mission Group, Shaires Holdings, Eleco Public, Futura Medical and Scancell Holdings are today's biggest movers on London's AIM market
AIM Market Roundup: Sunrise Resources, Futura Medical, Plexus
Sunrise Resources, Futura Medical, Plexus, Celsius Resources and CPP are today's biggest movers on London's AIM market
Futura Medical Earnings Call Transcript: H2 2025
2025 saw a strategic reset with sharply lower revenues, cost base alignment, and a focus on disciplined cash management. Eroxon Intense and WSD4000 development advanced, with launches targeted for 2027 and 2028, and APAC expansion prioritized.
Futura Medical Annual report: H2 2025
Futura Medical has published its H2 2025 annual report on April 29, 2026.
Futura Medical Slides: H2 2025
Futura Medical has posted slides in relation to its H2 2025 quarterly earnings report, which was published on April 29, 2026.
Futura Medical Annual report: H2 2025
Futura Medical has published its H2 2025 annual report on April 29, 2026.
Futura Medical Earnings release: Q4 2025
Futura Medical released its Q4 2025 earnings on February 4, 2026, summarizing the period's financial results.
Futura Medical Earnings Call Transcript: H1 2025
H1 2025 saw disappointing repeat sales and revenue, leading to a significant downgrade in full-year expectations and a strategic review. Cash runway extends into January 2026, with new product launches and financing options under active consideration.
Futura Medical Quarterly report: H1 2025
Futura Medical has published its H1 2025 quarterly earnings report on September 30, 2025.
Futura Medical Slides: H1 2025
Futura Medical has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 30, 2025.